RET-Positive Metastatic NSCLC
Playback speed
10 seconds
WCLC 2022 on the Phase 3 SANOVO Study: Savolitinib or Placebo in Combination With Osimertinib in EGFRm and MET Overexpressed NSCLC
By
WCLC 2022 Conference Coverage
FEATURING
Qing Zhou
By
WCLC 2022 Conference Coverage
FEATURING
Qing Zhou
168 views
August 18, 2022
Login to view comments.
Click here to Login